Arpeggio Bio uses machine learning and RNA to make drugs against previously undruggable targets in cancer and inflammation diseases.
Aspero Medical, Inc.
Aspero Medical focuses on improving gastrointestinal endoscopy for the patient and physician. Their technology enhances device performance, saving time and money, while improving patient outcomes.
BCell Solutions, Inc.
BCell Solutions' proprietary peptide immunotherapy is designed to treat newly discovered underlying causes of inflammation and a broad range of diseases driven by unwanted inflammation.
BromeCare Therapeutics, LLC
BromeCare Therapeutics is rapidly developing a plant-derived therapeutic which disrupts SARS-CoV-2 spike protein as well as altering the ACE-2 and TMPRSS2 receptors that SARS-CoV-2 uses to gain entry into human cells for use in the treatment and prevention of COVID-19.
CellDrop Biosciences, Inc.
CellDrop is commercializing a stem cell therapy developed to quickly and permanently heal musculoskeletal injuries in race horses.
Double Helix Optics
Double Helix Optics is designing and manufacturing sensors and imaging modules for precision 3D imaging used in life and material sciences, industrial inspection and machine vision to enable imaging and tracking of objects from single molecules inside cells (10-15 nm) to hand/face recognition with detailed 3D information utilizing patented light engineering technology.
EvoEndo® builds innovative pediatric endoscopy systems allowing diagnostic upper endoscopies to be performed comfortably and quickly in children without the use of general anesthesia.
GPER G-1 Development Group
GPER G-1 Dev. Group is developing a novel therapeutic for the treatment of diabetes and obesity.
Inherent Biosciences, Inc.
Inherent Biosciences is a molecular diagnostics company at the intersection of epigenetics and artificial intelligence tackling clinical problems where epigenetics appears to be involved, namely: infertility, autoimmune disease, autism, and now COVID-19 disease severity and treatment response.
Laporte Immunotherapeutics, Inc. is a pre-clinical stage biopharmaceutical company developing transformative immune-based therapies for upper respiratory and eye infections, using immune stimulatory nanoparticles to activate immune defenses in the nose and eye.
Localis Therapeutics, LLC
Localis Therapeutics translates patented technologies that locally suppress the immune response to a tissue transplant that is safer and more cost effective compared to the current standard of systemic (whole body) immunosuppression.
Based on Nobel Prize-winning dual comb laser technology from NIST and CU Boulder, LongPath is attacking the climate change problem of undetected methane emissions from active oil wells by providing the lowest cost highest precision continuous methane monitoring for oil field installations in the world.
LumenAstra is commercializing a wearable, non-invasive core body temperature sensor with impactful applications in tumor hyperthermia therapy and monitoring brain temperature for neonates and stroke/brain injury patients to prevent additional brain damage during the critical hours post-injury.
Majelco Medical, Inc.
Majelco Medical, Inc. is a seed-stage company that is developing a proprietary, disposable device to measure surgical blood loss accurately and in real-time, enabling improved patient outcomes and decreased healthcare costs for approximately 10 million surgeries every year in the U.S. alone.
Microsurgical Innovations (MSI) develops medical devices for use in microsurgical applications. MSI's first product for commercialization, a Vascular Coupling System (VCS), is intended to replace the hand suturing technique currently used to connect arteries and veins in microvascular and macrovascular end-to-end vascular repair surgeries.
Nob Hill Therapeutics
Nobhill Therapeutics (NHT) is commercializing a first of its kind, dry powder nebulizer technology, DryNebTM, by developing effective inhalation therapies to treat deadly lung infections.
Nutriwyo is developing a novel treatment strategy for diabetic wounds.
Osazda Energy’s patented technology extends the operational lifetime of solar panels by reducing degradation due to cracking, which results in higher profitability for solar cell manufacturers and solar farm owners.
PhotonPharma is an immune oncology company that has developed a breakthrough technology to stimulates a patient’s own immune system to seek out and destroy their cancer cells.
PurCell Bio, Inc.
PurCell Bio is developing a line of chemically defined, complete serum replacements specifically designed for individual cell types. These supplements minimize variability of results and eliminate contamination potential associated with serum and animal derived protein use. They support cells as well or better than serum and are similar in price.
Pure Blue Tech, Inc.
Pure Blue Tech is developing the world's most productive, efficient and low-fouling membrane elements for desalination, wastewater treatment and industrial processing.
Resono Pressure Systems
Resono provides novel unsteady pressure measurement solutions for advanced aerospace and energy applications.
Scribe Sciences is developing a modern datalogger that allows users to seamlessly collect data end-to-end into a standardized environment to maximize the ability to leverage data for real time alerts, visualizations and predictive applications.
Socialcontext.ai provides an AI-powered brand safety floor that protects and enables the monetization of diversity, equality, and inclusion news and social media content.
Soil Metrics provides computation modeling for greenhouse gas emissions and sequestration in croplands and rangelands enabling farmers to earn soil carbon credits through the adoption of conservation practices.